HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

cholestenoic acid

structure in first source

Also Known As:

5-cholesten-3-ol-25-carboxylic acid

Networked: 6 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Polycyclic Compounds: 6
- Fused-Ring Compounds
  - Steroids: 70059
    - Cholestanes
      - Cholestenes
        cholestenoic acid: 6

Experts

1.	Griffiths, William J: 2 articles (01/2019 - 11/2014)
2.	Gustafsson, Jan-Åke: 2 articles (01/2019 - 11/2014)
3.	Wang, Yuqin: 2 articles (01/2019 - 11/2014)
4.	Abdel-Khalik, Jonas: 1 article (01/2019)
5.	Dixon, Anne E: 1 article (01/2019)
6.	Fessler, Michael B: 1 article (01/2019)
7.	Garantziotis, Stavros: 1 article (01/2019)
8.	Janssen, William J: 1 article (01/2019)
9.	Lih, Fred B: 1 article (01/2019)
10.	Lowe, Julie M: 1 article (01/2019)

Related Diseases

1.	Frontotemporal Dementia (Semantic Dementia) 01/01/2019 - "Using liquid chromatography - mass spectrometry in combination with derivatisation chemistry we profiled the oxysterol and cholestenoic acid content of cerebrospinal fluid from patients with Alzheimer's disease (n = 21), vascular dementia (n = 11), other neurodegenerative diseases (n = 15, Lewy bodies dementia, n = 3, Frontotemporal dementia, n = 11) and controls (n = 15). "
2.	Atherosclerosis 01/01/2005 - "Patients with atherosclerosis may have increased circulating levels of 27-hydroxycholesterol and cholestenoic acid."
3.	Inborn Genetic Diseases (Disease, Hereditary) 11/01/2014 - "Mutations in CYP7B1 or CYP27A1, which encode enzymes involved in cholestenoic acid metabolism, result in different neurological diseases, hereditary spastic paresis type 5 (SPG5) and cerebrotendinous xanthomatosis (CTX), respectively. "
4.	Neurodegenerative Diseases (Neurodegenerative Disease) 01/01/2019 - "Using liquid chromatography - mass spectrometry in combination with derivatisation chemistry we profiled the oxysterol and cholestenoic acid content of cerebrospinal fluid from patients with Alzheimer's disease (n = 21), vascular dementia (n = 11), other neurodegenerative diseases (n = 15, Lewy bodies dementia, n = 3, Frontotemporal dementia, n = 11) and controls (n = 15). "
5.	Cerebrotendinous Xanthomatosis 11/01/2014 - "Mutations in CYP7B1 or CYP27A1, which encode enzymes involved in cholestenoic acid metabolism, result in different neurological diseases, hereditary spastic paresis type 5 (SPG5) and cerebrotendinous xanthomatosis (CTX), respectively. "

Related Drugs and Biologics

1.	Biomarkers (Surrogate Marker)
2.	Enzymes
3.	Cholesterol
4.	Oxysterols
5.	27-hydroxycholesterol